MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer

Pornima Phatak1,2,3, Whitney M Burrows4, Timothy Michael Creed5

  • 1Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA. pornima.phatak@va.gov.

BMC Cancer
|December 5, 2022
PubMed
Abstract

Insights

MicroRNA-214-3p acts as a tumor suppressor in esophageal cancer by regulating RAB14. Overexpressing miR-214-3p or silencing RAB14 inhibits cancer cell migration and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA (miR)-214-3p is recognized as a potential tumor suppressor in esophageal cancer.
  • RAB14, a membrane trafficking protein, exhibits oncogenic properties in various cancers.

Purpose of the Study:

  • To investigate the interaction between miR-214-3p and RAB14 in esophageal cancer.
  • To elucidate the role of miR-214-3p in regulating RAB14 expression and its impact on esophageal cancer progression.

Main Methods:

  • Expression analysis of miR-214-3p in esophageal cancer cell lines and human specimens using digital PCR.
  • Assessment of miR-214-3p and RAB14 mRNA/protein interaction via biotinylated RNA pull-down and luciferase reporter assays.
  • Evaluation of cell migration and invasion using the xCELLigence RTCA system and in vivo tumor growth in a murine model.

Main Results:

  • Esophageal cancer tissues and cell lines showed reduced miR-214-3p expression compared to normal controls.
  • Overexpression of miR-214-3p led to decreased RAB14 mRNA stability and protein levels, confirming their binding.
  • Both miR-214-3p overexpression and RAB14 silencing significantly reduced esophageal cancer cell migration and invasion.
  • Stable miR-214-3p expression in esophageal cancer cells resulted in diminished tumor growth in vivo.

Conclusions:

  • miR-214-3p functions as a tumor suppressor in esophageal cancer.
  • The tumor-suppressive activity of miR-214-3p is mediated through the regulation of RAB14 expression.
  • Targeting the miR-214-3p/RAB14 axis may offer therapeutic strategies for esophageal cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K